Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor

被引:250
作者
Hackeng, TM [1 ]
Seré, KM [1 ]
Tans, G [1 ]
Rosing, J [1 ]
机构
[1] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6229 ER Maastricht, Netherlands
关键词
anticoagulant; venous thrombosis; extrinsic coagulation;
D O I
10.1073/pnas.0504240103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tissue factor (TF) plays an important role in hemostasis, inflammation, angiogenesis, and the pathophysiology of atherosclerosis and cancer. In this article we uncover a mechanism in which protein S, which is well known as the cofactor of activated protein C, specifically inhibits TF activity by promoting the interaction between full-length TF pathway inhibitor (TFPI) and factor Xa (FXa). The stimulatory effect of protein S on FXa inhibition by TFPI is caused by a 10-fold reduction of the K-i of the FXa/TFPI complex, which decreased from 4.4 nM in the absence of protein S to 0.5 nM in the presence of protein S. This decrease in Ki not only results in an acceleration of the feedback inhibition of the TF-mediated coagulation pathway, but it also brings the TFPI concentration necessary for effective FXa inhibition well within range of the concentration of TFPI in plasma. This mechanism changes the concept of regulation of TF-induced thrombin formation in plasma and demonstrates that protein S and TFPI act in concert in the inhibition of TF activity. Our data suggest that protein S deficiency not only increases the risk of thrombosis by impairing the protein C system but also by reducing the ability of TFPI to down-regulate the extrinsic coagulation pathway.
引用
收藏
页码:3106 / 3111
页数:6
相关论文
共 47 条
[1]   Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor [J].
Ahamed, J ;
Belting, M ;
Ruf, W .
BLOOD, 2005, 105 (06) :2384-2391
[2]   Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain [J].
Ahamed, J ;
Ruf, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (22) :23038-23044
[3]   Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor [J].
Baugh, RJ ;
Broze, GJ ;
Krishnaswamy, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4378-4386
[4]   Regulation of angiogenesis by tissue factor cytoplasmic domain signaling [J].
Belting, M ;
Dorrell, MI ;
Sandgren, S ;
Aguilar, E ;
Ahamed, J ;
Dorfleutner, A ;
Carmeliet, P ;
Mueller, BM ;
Friedlander, M ;
Ruf, W .
NATURE MEDICINE, 2004, 10 (05) :502-509
[5]   TISSUE FACTOR PATHWAY INHIBITOR AND THE REVISED THEORY OF COAGULATION [J].
BROZE, GJ .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :103-112
[6]   Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa [J].
Camerer, E ;
Huang, W ;
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5255-5260
[7]   Role of tissue factor in embryonic blood vessel development [J].
Carmeliet, P ;
Mackman, N ;
Moons, L ;
Luther, T ;
Gressens, P ;
VanVlaenderen, I ;
Demunck, H ;
Kasper, M ;
Breier, G ;
Evrard, P ;
Muller, M ;
Risau, W ;
Edgington, T ;
Collen, D .
NATURE, 1996, 383 (6595) :73-75
[8]   Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis [J].
Dahm, A ;
Vlieg, AV ;
Bendz, B ;
Rosendaal, F ;
Bertina, RM ;
Sandset, PM .
BLOOD, 2003, 101 (11) :4387-4392
[9]  
DIAZCOLLIER JA, 1994, THROMB HAEMOSTASIS, V71, P339
[10]  
ESMON CT, 1989, J BIOL CHEM, V264, P4743